ArticleFrontiers in virology (Lausanne, Switzerland)2026
Iterative immunoprecipitation and phage pre-wash dramatically improve epitope-resolved serology by VirScan.
Article in Frontiers in virology (Lausanne, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
Accurate mapping of antibody epitope repertoires is essential for understanding infection, vaccination, and immune history. Phage immunoprecipitation sequencing (PhIP-seq), including the widely used VirScan platform, offers single - peptide resolution across the human virome; however, such measurements are sometimes beset with limitations stemming from weak signal-to-noise ratio, non-specific phage binding, and inconsistent peptide enrichment. With such methods, it is imperative to differentiate true antibody-antigen interactions from background noise. Here, we systematically evaluate the impact of key experimental variables on assay performance and identify two synergistic modifications that markedly improve epitope-level viral serology: (1) iterative rounds of immunoprecipitation and (2) serum pre-washing with wild-type phage. Across healthy donor sera, pooled HIV-seropositive sera, and influenza-vaccinated rabbit sera, the optimized workflow produces a substantial expansion of the enriched peptide population, significantly higher normalized peptide counts, and improved separation of viral epitopes from background noise while preserving global library representation. The protocol enables quantitative detection of HIV epitopes across a 100-fold dilution series, resolving immunodominant gp160 regions, and identifies strain-specific hemagglutinin epitopes elicited by influenza vaccination, including expected public stem-directed linear epitopes. These results provide a reproducible, generalizable workflow that enhances viral epitope discovery, serosurveillance sensitivity, and vaccine-response mapping. This optimized PhIP-seq framework strengthens the utility of VirScan in systems virology by enabling more accurate and quantitative inference of viral antibody repertoires.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.